Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy Factors for PRP in Elbow Tendinopathy
NCT06815042Phase 4Not yet recruiting
- Sponsor
- CHA University
- Start
- Feb 2025
- Primary completion
- Dec 2025
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of autologous platelet-rich plasma in elbow tendinopathy, sponsored by CHA University. Primary endpoint: Patient-Rated Tennis Elbow Evaluation at 4 weeks. Planned start Feb 2025; status: not yet recruiting.
02
Drugs
autologous platelet-rich plasma
03
Conditions
elbow tendinopathy
Beyond the preview
Go deeper on NCT06815042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06815042.